Beaconcure key facts
as of Oct 2026- Developer of statistical analysis validation software designed to improve mission-critical business challenges in drug development and regulatory approvals.
- Beaconcure is valued at approximately $32.5M as of Oct 2026, set at its later-stage round, Jan 2025; nothing has traded since, per PrivateMarketView’s mark.
- It has raised $20.7M across 3 recorded rounds; the latest was Early Stage VC ($15.0M) in Jan 2025.
- Notable investors include Innovation Authority, Keihanna Global Acceleration Program, Deloitte Launchpad, Green Innovations, NewVale Capital — 6 tracked in total.
- Beaconcure has filed 3 Form Ds with the SEC since 2021, most recently Jan 2025 ($15.0M sold to 5 investors).
- Status: Privately Held (backing).
Valued at $32.5M at its later-stage round, Jan 2025. Nothing has traded since.
- ·Watch Beaconcure: the Monday email on marks, rounds and moves
Beaconcure funding rounds
3 roundsBeaconcure valuation
Beaconcure was valued at $32.5 million at its later-stage round in Jan 2025. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.
How much has Beaconcure raised?
Beaconcure has raised $20.7 million across 3 recorded rounds since 2021. The largest was a $9.9 million early-stage round in Feb 2023; the most recent was a $15 million early-stage round in Jan 2025.
Beaconcure has filed 3 Form Ds with the SEC since 2021, most recently in Jan 2025 ($15 million sold to 5 investors).
Beaconcure investors
6 investors are on record for Beaconcure, including Innovation Authority, Keihanna Global Acceleration Program, Deloitte Launchpad and Green Innovations. The early-stage round in Jan 2025 drew 5 investors.
About Beaconcure
Developer of statistical analysis validation software designed to improve mission-critical business challenges in drug development and regulatory approvals. The company's software offers query development, discovery, and fulfillment tools that use proprietary algorithms to generate data from evolving databases to save critical time, reduce human error, and accelerate regulatory approval to validate clinical trial data, enabling clients to gain meaningful value for their decision-making process.
- Sector
- Healthcare
- HQ
- Boston, MA, United States
- Founded
- 2016
- Employees
- 36
- Website
- beaconcure.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.